Literature DB >> 29693501

Improving Research in Radiation Oncology through Interdisciplinary Collaboration.

Jay W Burmeister1, Monica W Tracey2, Sara E Kacin2, Michael M Dominello1, Michael C Joiner1.   

Abstract

The contribution of radiation oncology to the future of cancer treatment depends significantly on our continued clinical progress and future research advancements. Such progress relies on multidisciplinary collaboration among radiation oncologists, medical physicists and radiobiologists. Cultivating collaborative educational and research opportunities among these three disciplines and further investing in the infrastructure used to train both clinicians and researchers will therefore help us improve the future of cancer care. This article evaluates the success of a short-term educational environment to foster multidisciplinary collaboration. The NIH-funded educational course developed at Wayne State University, called "Integration of Biology and Physics into Radiation Oncology" (IBPRO), was designed to facilitate the engagement of radiation oncologists, medical physicists and radiobiologists in activities that enhance collaborative investigation. Having now been delivered to nearly 200 participants over the past four years, the relative success of IBPRO in fostering productive interdisciplinary collaboration and producing tangible research outcomes can be evaluated. The 140 IBPRO participants from the first three years were surveyed to quantify the effectiveness of the course. In total, 62 respondents reported developing 23 institutional protocols, submitting more than 25 research grants (nine of which have been funded thus far), and publishing more than 30 research manuscripts attributable to participation in IBPRO. Nearly one-half (45%) of respondents reported generating at least one of these research metrics attributable to participation in IBPRO and these participants reported an average of over four such quantitative research metrics per respondent. This represents a very substantial contribution to radiation oncology research by a relatively small number of researchers within a relatively short time. Nearly one-half of respondents reported ongoing collaborative working relationships generated by IBPRO. In addition, approximately one-half of respondents stated that specific information presented at IBPRO changed the way they practice, and over 80% of respondents practicing in a clinical setting stated that, since participation in IBPRO, they have approached clinical dilemmas more collaboratively. We believe that educational opportunities such as IBPRO can have a significant impact on interdisciplinary collaborative research. In addition, such interventions have the ability to effect significant clinical change. Both of these should have a positive impact on future advancements in radiation oncology and affect the future contribution of radiation oncology to the treatment of cancer.

Entities:  

Mesh:

Year:  2018        PMID: 29693501      PMCID: PMC6052437          DOI: 10.1667/RR15023.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  11 in total

1.  Training in the radiation sciences: a national and international need.

Authors:  Sara Rockwell
Journal:  Radiat Res       Date:  2003-06       Impact factor: 2.841

2.  Education and Training Needs in the Radiation Sciences: Problems and Potential Solutions.

Authors:  Joseph R Dynlacht; Elaine M Zeman; Kathryn D Held; James Deye; Bhadrasain Vikram; Michael C Joiner
Journal:  Radiat Res       Date:  2015-10-19       Impact factor: 2.841

3.  Raising the next generation of physician-scientists: the chairs' perspective.

Authors:  Silvia C Formenti; James F Bonner; Stephen M Hahn; Theodore S Lawrence; Fei-Fei Liu; Charles R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-01       Impact factor: 7.038

Review 4.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

5.  The American Society for Radiation Oncology's 2015 Core Physics Curriculum for Radiation Oncology Residents.

Authors:  Jay Burmeister; Zhe Chen; Indrin J Chetty; Sonja Dieterich; Anthony Doemer; Michael M Dominello; Rebecca M Howell; Patrick McDermott; Adrian Nalichowski; Joann Prisciandaro; Tim Ritter; Chadd Smith; Eric Schreiber; Timothy Shafman; Steven Sutlief; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-03-19       Impact factor: 7.038

6.  IBPRO - A Novel Short-Duration Teaching Course in Advanced Physics and Biology Underlying Cancer Radiotherapy.

Authors:  Michael C Joiner; Monica W Tracey; Sara E Kacin; Jay W Burmeister
Journal:  Radiat Res       Date:  2017-03-22       Impact factor: 2.841

7.  Toward a national consensus: teaching radiobiology to radiation oncology residents.

Authors:  Elaine M Zeman; Joseph R Dynlacht; Barry S Rosenstein; Mark W Dewhirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

8.  American Society for Radiation Oncology (ASTRO) 2012 Workforce Study: the radiation oncologists' and residents' perspectives.

Authors:  Surjeet Pohar; Claire Y Fung; Shane Hopkins; Robert Miller; Samar Azawi; Anna Arnone; Caroline Patton; Christine Olsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-22       Impact factor: 7.038

9.  Navigating the medical physics education and training landscape.

Authors:  Brian Loughery; George Starkschall; Kristi Hendrickson; Joann Prisciandaro; Brenda Clark; Gary Fullerton; Geoffrey Ibbott; Edward Jackson; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2017-11       Impact factor: 2.102

10.  Essentials and guidelines for clinical medical physics residency training programs: executive summary of AAPM Report Number 249.

Authors:  Joann I Prisciandaro; Charles E Willis; Jay W Burmeister; Geoffrey D Clarke; Rupak K Das; Jacqueline Esthappan; Bruce J Gerbi; Beth A Harkness; James A Patton; Donald J Peck; Robert J Pizzutiello; George A Sandison; Sharon L White; Brian D Wichman; Geoffrey S Ibbott; Stefan Both
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

View more
  10 in total

1.  Radiation therapy technologists' involvement and opinion in research: A national survey in Italy.

Authors:  D Piro; L Boldrini; P Cornacchione; C Votta; M Bianchi; M Balducci; M A Gambacorta; V Valentini; D Pasini
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2020-06-20

2.  Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

Authors:  Pranshu Mohindra; Amit Sawant; Robert J Griffin; Narottam Lamichhane; Erina Vlashi; Meng Xu-Welliver; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-22       Impact factor: 2.102

3.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Authors:  Steve Braunstein; Li Wang; Wayne Newhauser; Todd Tenenholz; Yi Rong; Albert van der Kogel; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-08       Impact factor: 2.102

4.  Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology.

Authors:  Leonard Kim; Stephanie Markovina; Samantha J Van Nest; Subarna Eisaman; Lakshmi Santanam; Julie M Sullivan; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-05-25       Impact factor: 2.102

5.  Three Discipline Collaborative Radiation Therapy (3DCRT) special debate: In the future, at least 20% of NIH funding for radiotherapy research should be allocated to non-oncologic applications.

Authors:  Krisha Howell; Martha Matuszak; Charles A Maitz; Subarna H Eisaman; Laura Padilla; Stephen L Brown; Michael C Joiner; Michael M Dominello; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

6.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

7.  Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response.

Authors:  Clemens Grassberger; Kathryn Huber; Naduparambil K Jacob; Michael D Green; Peter Mahler; Joann Prisciandaro; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

8.  Three discipline collaborative radiation therapy (3DCRT) special debate: A physicist's time is better spent in direct patient/provider interaction than in the patient's chart.

Authors:  Todd F Atwood; Narottam Lamichhane; Krisha Howell; Stephanie E Weiss; Louise Bird; Charles Pearson; Michael C Joiner; Michael M Dominello; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2022-02-15       Impact factor: 2.243

9.  Research disciplinary interactions on scientific collaboration network in photocatalytic hydrogen evolution: Characteristics and dynamics.

Authors:  Xiaojie Yao; Yuan Hu; Xiaomin Zou; Wenjian Qu
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.752

10.  Three discipline collaborative radiation therapy (3DCRT) special debate: FLASH radiotherapy needs ongoing basic and animal research before implementing it to a large clinical scale.

Authors:  Patrizia Guerrieri; Naduparambil K Jacob; Peter G Maxim; Amit Sawant; Samantha J Van Nest; Pranshu Mohindra; Michael M Dominello; Jay W Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2022-02-01       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.